Fiduciary Trust Company »

Akebia Therapeutics shares owned by Fiduciary Trust Company

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Fiduciary Trust Company from 13F filings

Historical chart of Fiduciary Trust Company investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Fiduciary Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Fiduciary Trust Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $161k 100k 1.61

More positions owned by Fiduciary Trust Company

Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
TJX Companies (TJX)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Vanguard Tax Managed Intl Ftse Dev Mkt Etf (VEA)
Coupang Cl A (CPNG)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
First Tr Exchange-traded Energy Inm Partn (EIPX)
Wisdomtree Tr Earning 500 FD (EPS)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Fiduciary Trust Company

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Goldman Sachs Group
Renaissance Technologies
Citadel Advisors
Qube Research & Technologies
Millennium Management
Northern Trust
Acadian Asset Management
Charles Schwab Investment Management
Nantahala Capital Management
Hrt Financial
Dimensional Fund Advisors

View all funds holding Akebia Therapeutics